UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 11-K
FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS
AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
(Mark One)
x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2016
OR
o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number
A. Full title of the plan and the address of the plan, if different from that of the issuer named below:
ABBOTT LABORATORIES STOCK RETIREMENT PROGRAM
B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:
ABBOTT LABORATORIES
100 Abbott Park Road
Abbott Park, Illinois 60064-6049
FINANCIAL STATEMENTS AND
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ABBOTT LABORATORIES STOCK RETIREMENT PLAN
DECEMBER 31, 2016 AND 2015
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Plan Administrator
Abbott Laboratories Stock Retirement Plan
We have audited the accompanying statements of net assets available for benefits of the Abbott Laboratories Stock Retirement Plan (the Plan) as of December 31, 2016 and 2015, and the related statement of changes in net assets available for benefits for the year ended December 31, 2016. These financial statements are the responsibility of the Plans management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Plans internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Plans internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the net assets available for benefits of the Abbott Laboratories Stock Retirement Plan as of December 31, 2016 and 2015, and the changes in net assets available for benefits for the year ended December 31, 2016, in conformity with accounting principles generally accepted in the United States of America.
The supplemental information in the accompanying schedule of assets (held at end of year) as of December 31, 2016, has been subjected to audit procedures performed in conjunction with the audit of Abbott Laboratories Stock Retirement Plans financial statements. The supplemental information is presented for purposes of additional analysis and is not a required part of the basic financial statements but include supplemental information required by the
Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. The supplementary information is the responsibility of the Plans management. Our audit procedures included determining whether the supplemental information reconciles to the basic financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information in the accompanying schedule, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information referred to above is fairly stated, in all material respects, in relation to the basic financial statements taken as a whole.
/s/ Grant Thornton LLP
Chicago, Illinois
June 28, 2017
Abbott Laboratories Stock Retirement Plan
STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS
December 31,
(Dollars in thousands)
|
|
2016 |
|
2015 |
| ||
Assets |
|
|
|
|
| ||
Cash |
|
$ |
1,215 |
|
$ |
2,752 |
|
Investments, at fair value |
|
6,196,715 |
|
6,194,129 |
| ||
Notes receivable from participants |
|
62,960 |
|
74,996 |
| ||
Accrued interest and dividend income |
|
1,709 |
|
904 |
| ||
Due from brokers |
|
940 |
|
2,122 |
| ||
|
|
|
|
|
| ||
Total assets |
|
6,263,539 |
|
6,274,903 |
| ||
|
|
|
|
|
| ||
Liabilities |
|
|
|
|
| ||
Accrued investment expenses |
|
553 |
|
202 |
| ||
Due to brokers |
|
2,433 |
|
32,748 |
| ||
|
|
|
|
|
| ||
Total liabilities |
|
2,986 |
|
32,950 |
| ||
|
|
|
|
|
| ||
NET ASSETS AVAILABLE FOR BENEFITS |
|
$ |
6,260,553 |
|
$ |
6,241,953 |
|
The accompanying notes are an integral part of these statements.
Abbott Laboratories Stock Retirement Plan
STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS
Year ended December 31, 2016
(Dollars in thousands)
Additions |
|
|
| |
Contributions |
|
|
| |
Employer |
|
$ |
81,178 |
|
Participant |
|
163,926 |
| |
Rollovers |
|
12,864 |
| |
|
|
|
| |
Total contributions |
|
257,968 |
| |
|
|
|
| |
Investment income |
|
|
| |
Net appreciation in fair value of investments |
|
81,093 |
| |
Interest and dividends |
|
158,319 |
| |
|
|
|
| |
Net investment income |
|
239,412 |
| |
|
|
|
| |
Interest income on notes receivable from participants |
|
2,235 |
| |
|
|
|
| |
Total additions |
|
499,615 |
| |
|
|
|
| |
Deductions |
|
|
| |
Benefits paid to participants |
|
481,348 |
| |
Other expenses |
|
15 |
| |
|
|
|
| |
Total deductions |
|
481,363 |
| |
|
|
|
| |
Net increase prior to transfer |
|
18,252 |
| |
|
|
|
| |
Plan transfers in (note A) |
|
348 |
| |
|
|
|
| |
NET INCREASE AFTER TRANSFER |
|
18,600 |
| |
|
|
|
| |
Net assets available for benefits |
|
|
| |
Beginning of year |
|
6,241,953 |
| |
|
|
|
| |
End of year |
|
$ |
6,260,553 |
|
The accompanying notes are an integral part of this statements.
Abbott Laboratories Stock Retirement Plan
December 31, 2016 and 2015
NOTE A - DESCRIPTION OF THE PLAN
The following description of the Abbott Laboratories Stock Retirement Plan (the Plan) provides only general information. Participants should refer to the Plan document for a more complete description of the Plans provisions.
General
In general, United States employees of Abbott Laboratories (Abbott) and selected participating subsidiaries and affiliates may, after meeting certain employment requirements, voluntarily participate in the Plan. The Plan is intended to constitute a profit sharing plan under Section 401(a) of the Internal Revenue Code of 1986, as amended (the IRC), with a cash or deferred arrangement under IRC Section 401(k), and a portion of the Plan is intended to constitute an employee stock ownership plan that meets the applicable requirements of IRC Sections 409 and 4975(e)(7). The Plan is subject to the Employee Retirement Income Security Act of 1974, as amended (ERISA).
As of the year ended December 31, 2015, Mercer Trust Company and Mercer HR Services LLC (collectively, Mercer) were the custodian (Custodian), trustee (Trustee) and record keeper of the Plan. In January 2016, the Plan changed the record keeper of the Plan from Mercer to Hewitt Associates LLC, and the Custodian and Trustee from Mercer to The Northern Trust Company (Trustee thereafter).
During 2016, the Tendyne Holdings, Inc. 401(k) Plan merged into the Plan. Assets totaling approximately $348,000 transferred into the Plan.
Contributions and Vesting
Contributions to the Plan are paid to the Abbott Laboratories Stock Retirement Trust (Trust). The Trust is administered by the Trustee and an investment committee (the Committee).
Employees are eligible to commence participation in the Plan on any entry date following their date of hire. Eligible employees electing to participate contribute from 2% up to 25% of their eligible earnings, subject to certain limitations. Participants who have attained age 50 before the end of the Plan year and who are making the maximum pretax contributions are eligible to make catch-up contributions. The Plan also permits Roth 401(k) contributions and has a Roth 401(k) conversion feature. Participants may choose to make their contributions from pretax earnings, after-tax earnings, or both. The pretax contributions are a pay conversion feature, which is a salary deferral option under the provisions of Section 401(k) of the IRC. Participants may elect to invest their contributions in any or all of the investment options available under the Plan, except for investment options closed to new contributions.
Abbott Laboratories Stock Retirement Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE A - DESCRIPTION OF THE PLAN - Continued
Contributions and Vesting - Continued
Employer contributions to the Plan are made each payroll period based on the participating employees eligible earnings. The amount of the employer contribution was determined by the Board of Directors of Abbott and, for the year ended December 31, 2016, was 5% of the participants eligible earnings if the participant elected to contribute at least 2% of eligible earnings to the Plan. Employer contributions are invested each pay period according to the participants investment elections.
Cash dividends on Abbott common shares are (1) paid in cash to the participants or beneficiaries, (2) paid to the Plan and distributed in cash to participants or beneficiaries no later than 90 days after the close of the Plan year for which paid or (3) paid to the Plan and credited to the accounts in which shares are held, as elected by each participant or beneficiary in accordance with rules established by the administrator.
On January 1, 2013, Abbott separated into two publicly traded companies Abbott and AbbVie Inc. (AbbVie). The separation of Abbott and AbbVie was a tax-free distribution where Abbott shareholders received one share of AbbVie stock for every share of Abbott held as of the close of business on December 12, 2012, the record date for the distribution. Participants who received AbbVie stock through this distribution may continue to hold the stock in their Plan accounts but may not make new contributions or transfer existing contributions or earnings to purchase AbbVie stock in the Plan; however, participants may elect to reinvest their AbbVie dividends in AbbVie stock. If no election is made, AbbVie dividends are invested in the Plans default investment option.
Participants may direct the Trustee to sell all or a portion of the Abbott and AbbVie common shares held in their accounts and reinvest the proceeds in any of the other available investment options.
Participants are at all times fully vested in their own contributions and earnings thereon. Vesting in employer contributions and earnings thereon is based on the following vesting schedule:
|
|
Vesting |
|
Service |
|
percentage |
|
Less than two years |
|
0 |
% |
Two years or more |
|
100 |
% |
Non-vested portions of employer contributions and earnings thereon are forfeited as of an employees termination date. Forfeitures are used to (1) restore any forfeitures of participants who returned to service with Abbott within a given period of time, (2) pay Plan expenses and (3) reduce future employer contributions if terminated participants do not return to service within the given period of
Abbott Laboratories Stock Retirement Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE A - DESCRIPTION OF THE PLAN - Continued
Contributions and Vesting - Continued
time. In 2016, forfeitures reduced Abbotts employer contributions by approximately $1,504,000. Approximately $351,500 and $30,000 in forfeitures were available at the end of 2016 and 2015, respectively.
Distributions and In-Service Withdrawals
Following retirement, termination or death (or for some participants from merged-in plans, upon disability), participants or their beneficiaries may elect to receive a distribution in installments, in a single lump sum or in a partial lump sum. Participants may elect a direct rollover of their accounts. Also, upon termination, participants may elect to defer distribution to a future date but, after termination of employment, distribution must be made by the 1st of April following the year the participant reaches age 70 ½ or, if earlier, the 1st of April following the year in which the participant dies. Interest, dividends and other earnings will continue to accrue on such deferred amounts.
Prior to termination, participants are permitted to withdraw their after-tax contributions (after-tax contributions made on or after January 8, 2016 may be withdrawn from the Plan only after being held for two or more years) and rollover contributions (including Roth rollover accounts and merged-in plan rollover accounts) and, after age 59 ½, may also withdraw pretax contributions. Distributions are made in cash or, to the extent contained in the participants account, a participant may elect distribution of Abbott and AbbVie common shares, and in each case, subject to certain limitations.
Notes Receivable from Participants
Participants may convert their vested accounts into one or two loans to themselves. The borrowing may not exceed the lesser of the current market value of the assets allocated to their vested accounts or 50% of all of their Plan accounts up to $50,000, subject to Internal Revenue Service (IRS) limitations and restrictions. Participants pay interest on such borrowings at the prime rate in effect at the time the participant loan is made. Loans must be repaid within five years (or by the employees anticipated retirement date, if sooner) unless the loan is used for the purchase of the primary residence of the employee, in which case the repayment period can be extended to a period of fifteen years (or until the employees anticipated retirement date, if sooner). Repayment is made through periodic payroll deductions or by sending in payments, but a loan may be repaid in a lump sum at any time. Post-termination loan repayments are permitted. For employees whose account is distributed during the repayment period, the balance of the outstanding loan is netted from their Plan distribution.
Abbott Laboratories Stock Retirement Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Accounting
The financial statements have been prepared using the accrual basis of accounting.
Adoption of New Accounting Rules
In May 2015, the Financial Accounting Standards Board (FASB) issued updated guidance related to fair value measurement and the disclosures for investments in certain entities that calculate net asset value (NAV) per share (or its equivalent). The updated guidance applies to reporting entities that elect to measure the fair value of certain investments using the NAV per share (or its equivalent) of the investment as a practical expedient. Prior to the updated guidance, investments valued using the practical expedient were categorized within the fair value hierarchy on the basis of when the investment is redeemable with the investee at NAV. The amendments remove the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the NAV per share practical expedient.
The amendments are effective for the Plan for fiscal years beginning after December 15, 2016 and apply retrospectively to all periods presented. Earlier application is permitted. The Plans administrator elected to adopt the amendments for the year ended December 31, 2016. Accordingly, the amendment was retrospectively applied resulting in the removal of the investments for which fair value is measured using the NAV per share practical expedient from the fair value tables in the Investment Valuation note. The total amount of the investments measured at NAV is disclosed so that total investments in the fair value tables can be reconciled to total investments at fair value on the statements of net assets.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and changes therein, and disclosure of contingent assets and liabilities. Actual results may differ from those estimates.
Investment Valuation
The Plan uses the following methods and significant assumptions to estimate the fair value of investments:
Common stock, mutual funds and futures contracts - Valued at the published market price per share or unit multiplied by the number of respective shares or units held.
Abbott Laboratories Stock Retirement Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
Investment Valuation - Continued
Collective trust funds and Private 40-Act mutual funds - Valued at the NAV provided by the administrator of the fund. The NAV is used as a practical expedient to estimate fair value. The NAV is based on the value of the underlying assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding. Redemption from the funds is permitted daily. The Private 40-Act mutual funds agree to redeem shares solely in cash up to the lesser of $250,000 or 1% of the funds net assets during any 90-day period for any one shareholder. In consideration of the best interests of the remaining shareholders, the Private 40-Act mutual funds reserve the right to pay any redemption proceeds exceeding this amount in whole or in part by a distribution in kind of securities held by the funds in lieu of cash. It is highly unlikely that shares would ever be redeemed in kind.
Corporate debt and government debt - Valued at the published market price or prices obtained from independent financial services industry-recognized vendors multiplied by the number of respective units held. Prices obtained from vendors are on the basis of bid or mid evaluations in accordance to a regions market convention, using factors which include but are not limited to market quotations, yields, maturities, and the bonds terms and conditions. Proprietary methods are used to arrive at the evaluated price, which represent the price a dealer would pay for a security.
Certificate of deposit - Valued at amortized cost, which approximates fair value given the instruments short duration of less than 130 days.
The following tables summarize the basis used to measure investments at fair value at December 31, 2016 and 2015 (dollars in thousands):
|
|
Basis of Fair Value Measurement |
|
|
| |||||||||||
2016 |
|
Quoted |
|
Significant |
|
Significant |
|
Measured at |
|
Total |
| |||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Common stock |
|
$ |
2,639,909 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
2,639,909 |
|
Mutual funds |
|
1,271,412 |
|
|
|
|
|
|
|
1,271,412 |
| |||||
Collective trust funds |
|
|
|
|
|
|
|
1,744,321 |
|
1,744,321 |
| |||||
Corporate debt |
|
|
|
196,609 |
|
|
|
|
|
196,609 |
| |||||
Government debt |
|
|
|
18,451 |
|
|
|
|
|
18,451 |
| |||||
Certificate of deposit |
|
|
|
16,525 |
|
|
|
|
|
16,525 |
| |||||
Private 40-Act mutual funds |
|
|
|
|
|
|
|
309,488 |
|
309,488 |
| |||||
Total investments at fair value |
|
$ |
3,911,321 |
|
$ |
231,585 |
|
$ |
|
|
$ |
2,053,809 |
|
$ |
6,196,715 |
|
Abbott Laboratories Stock Retirement Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
Investment Valuation - Continued
|
|
Basis of Fair Value Measurement |
|
|
| |||||||||||
2015 |
|
Quoted |
|
Significant |
|
Significant |
|
Measured at |
|
Total |
| |||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Common stock |
|
$ |
2,670,877 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
2,670,877 |
|
Mutual funds |
|
2,332,967 |
|
|
|
|
|
|
|
2,332,967 |
| |||||
Collective trust funds |
|
|
|
|
|
|
|
633,838 |
|
633,838 |
| |||||
Corporate debt |
|
|
|
232,186 |
|
|
|
|
|
232,186 |
| |||||
Government debt |
|
|
|
2,903 |
|
|
|
|
|
2,903 |
| |||||
Certificate of deposit |
|
|
|
2,002 |
|
|
|
|
|
2,002 |
| |||||
Private 40-Act mutual funds |
|
|
|
|
|
|
|
319,356 |
|
319,356 |
| |||||
Total investments at fair value |
|
$ |
5,003,844 |
|
$ |
237,091 |
|
$ |
|
|
$ |
953,194 |
|
$ |
6,194,129 |
|
The Private 40-Act mutual funds are not direct filing entities. These funds invest in fixed income instruments of varying maturities. The investment objective of one fund is to seek maximum current income and the other is to seek maximum total return, both being consistent with preservation of capital and liquidity.
Notes Receivable from Participants
Notes receivable from participants are measured at their unpaid balance plus any accrued but unpaid interest. Delinquent loans are reclassified as distributions based upon the terms of the Plan. No allowance for credit losses has been recorded as of December 31, 2016 or 2015.
Income Recognition
Purchases and sales of securities are recorded on a trade-date basis. Interest income is recorded on an accrual basis. Dividends are recorded on the ex-dividend date. Net realized and unrealized appreciation/depreciation is recorded in the accompanying statement of changes in net assets available for benefits as net appreciation in fair value of investments.
Administrative Expenses
Participants are charged transaction fees for loan processing and commissions on purchases and sales of Abbott shares and sales of AbbVie stock. Investment fees for mutual funds, collective trust, managed accounts and money market funds are charged against the net assets of the respective fund. Abbott pays other record-keeping and administration fees, where applicable.
Abbott Laboratories Stock Retirement Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
Payment of Benefits
Benefits are recorded when paid.
NOTE C - INVESTMENTS
Distributions of Abbott common shares and conversions of participants common share account balances to participant loans or other investment options are recorded at fair market value.
A summary of Abbott common share data as of December 31, 2016 and 2015 is presented below:
|
|
2016 |
|
2015 |
| ||
Abbott common shares, 31,314,205 and 30,896,195 shares, respectively (dollars in thousands) |
|
$ |
1,202,779 |
|
$ |
1,387,548 |
|
Market value per share |
|
$ |
38.41 |
|
$ |
44.91 |
|
In general, the investments provided by the Plan are exposed to various risks, such as interest rate, credit and overall market volatility risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participant accounts and the amounts reported in the statements of net assets available for benefits.
NOTE D - RELATED-PARTY AND PARTY-IN-INTEREST TRANSACTIONS
A significant portion of the Plans assets is invested in Abbott common shares.
Participants pay fees to the recordkeeper for loan transaction processing and for commissions on purchases and sales of Abbott shares and sales of AbbVie stock. These transactions qualify as permitted party-in-interest transactions.
Abbott Laboratories Stock Retirement Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE E - PLAN TERMINATION
The Plan may be terminated at any time by Abbott upon written notice to the Trustee and Committee. All participants account balances would become fully vested upon Plan termination. Upon termination of the Plan, distributions of each participants share in the Trust, as determined by the terms of the Plan, would be made to each participant. At the present time, Abbott has no intention of terminating the Plan.
NOTE F - TAX STATUS
The IRS has determined and informed Abbott by a letter dated April 23, 2014, that the Plan and related Trust are designed in accordance with applicable sections of the IRC. The Plan has been amended since the applicable date of the determination letter. However, the Plan administrator believes that the Plan is designed and is currently being operated, in all material respects, in accordance with the applicable requirements of the IRC.
Accounting principles generally accepted in the United States of America require Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the organization has taken an uncertain position that more likely than not would not be sustained upon examination by the IRS or other applicable taxing authorities. The Plan administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2016 and 2015, there are no uncertain positions taken or expected to be taken that would require recognition of a liability or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions, and an audit is currently in progress.
NOTE G SUBSEQUENT EVENTS
The Company has evaluated subsequent events from December 31, 2016 through the date these financial statements were issued. Other than described below, there were no subsequent events that require recognition or additional disclosure in these financial statements.
In January 2017, Abbott completed the acquisition of St. Jude Medical, Inc., a global medical device manufacturer. St. Jude Medical, LLC employees in the United States are currently eligible to participate in a separate plan, not the Plan.
Abbott Laboratories Stock Retirement Plan
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE G SUBSEQUENT EVENTS - Continued
In February 2017 Abbott completed the sale of Abbott Medical Optics (AMO), its vision care business, to Johnson & Johnson. AMO employees in the United States are no longer eligible make contributions to the Plan. AMO participants may keep their account balance in the Plan, elect to receive installment payments (subject to any applicable taxes), roll over their account to an IRA or another qualified plan, such as the Johnson & Johnson Savings Plan, or take a distribution subject to taxes and penalties. If an AMO participant elects to roll over their account to the Johnson & Johnson Savings Plan and the participant has an outstanding loan, for a limited time the loan balance may be rolled over to the Johnson & Johnson Savings Plan and loan repayments will continue at Johnson & Johnson.
Beginning March 2017, newly hired employees in certain specified Abbott divisions and business units participate in the Plan under a different structure (Abbott Green employees). Under the Abbott Green structure, participants may defer up to 50% of compensation as pre-tax or Roth contributions. Effective with the first pay period ending after March 1, 2017, for Abbott Green employees who are employed as of June 30, 2017, matching contributions will be made at the rate of either (i) 100% of a 1% deferral of eligible compensation or (ii) 5% of eligible compensation for a deferral of 2% or more of eligible compensation. A true-up matching contribution will be made for eligible participants as of the end of the year if necessary to reach a full 1% or 5% matching contribution, as applicable. The Abbott Green matching contributions vest 20% each year, until full vesting at five years (with accelerated vesting if the participant dies, attains age 65, or becomes disabled).
The Plan received a favorable determination letter from the IRS dated May 19, 2017 informing the Plan that it is designed in accordance with the applicable sections of the IRC.
Abbott Laboratories Stock Retirement Plan
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
December 31, 2016
(Dollars in thousands)
Identity of party involved/ |
|
|
|
Current |
| |
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
| |
|
|
|
|
|
| |
Common stock - employer securities |
|
|
|
|
| |
*ABBOTT LABORATORIES, common shares |
|
|
|
$ |
1,202,779 |
|
|
|
|
|
|
| |
Common stock |
|
|
|
|
| |
1ST HORIZON NATL CORP |
|
|
|
250 |
| |
5TH 3RD BANCORP |
|
|
|
1,107 |
| |
ABBVIE INC |
|
|
|
1,252,422 |
| |
ACADIA HEALTHCARE CO INC |
|
|
|
85 |
| |
ADIENT PLC ADIENT PLC LTD |
|
|
|
229 |
| |
AECOM |
|
|
|
298 |
| |
AES CORP |
|
|
|
412 |
| |
AFFILIATED MANAGERS GROUP INC |
|
|
|
52 |
| |
AGCO CORP |
|
|
|
214 |
| |
AGILENT TECHNOLOGIES INC |
|
|
|
589 |
| |
AGNC INVT CORP |
|
|
|
324 |
| |
AIR LEASE CORP |
|
|
|
91 |
| |
AKAMAI TECHNOLOGIES INC |
|
|
|
70 |
| |
ALASKA AIR GROUP INC |
|
|
|
103 |
| |
ALBEMARLE CORP |
|
|
|
518 |
| |
ALERE INC |
|
|
|
146 |
| |
ALEXANDRIA REAL ESTATE EQUITIES INC |
|
|
|
414 |
| |
ALLEGHANY CORP |
|
|
|
485 |
| |
ALLIANT ENERGY CORP |
|
|
|
465 |
| |
ALLIED WORLD ASSURANCE COMPANY |
|
|
|
255 |
| |
ALLISON TRANSMISSION HOLDING |
|
|
|
258 |
| |
ALLSCRIPTS HEALTHCARE SOLUTIONS INC |
|
|
|
102 |
| |
ALLY FINL INC |
|
|
|
453 |
| |
ALNYLAM PHARMACEUTICALS INC |
|
|
|
19 |
| |
AMDOCS |
|
|
|
464 |
| |
AMER FINL GROUP INC |
|
|
|
325 |
| |
AMER NATL INS CO |
|
|
|
47 |
| |
AMERCO |
|
|
|
44 |
| |
AMEREN CORP |
|
|
|
684 |
| |
AMERICAN AIRLINES INC |
|
|
|
1,325 |
| |
AMERICAN CAMPUS CMNTYS INC |
|
|
|
351 |
| |
AMERICAN HOMES 4 RENT |
|
|
|
185 |
| |
AMERICAN WTR WKS CO INC |
|
|
|
692 |
| |
AMERIPRISE FINL INC |
|
|
|
651 |
| |
AMETEK INC |
|
|
|
491 |
| |
AMTRUST FINL SVCS INC |
|
|
|
120 |
| |
ANALOG DEVICES |
|
|
|
424 |
| |
ANALOG DEVICES INC |
|
|
|
1,196 |
| |
ANNALY CAP MGMT INC |
|
|
|
546 |
| |
ANSYS INC |
|
|
|
325 |
| |
ANTERO RES CORP |
|
|
|
230 |
| |
APARTMENT INVT & MGMT CO |
|
|
|
381 |
| |
APPLE HOSPITALITY REIT INC |
|
|
|
174 |
| |
APTARGROUP INC |
|
|
|
181 |
| |
AQUA AMER INC |
|
|
|
289 |
| |
ARAMARK |
|
|
|
262 |
| |
ARCH CAPITAL GROUP |
|
|
|
531 |
| |
ARCONIC INC |
|
|
|
438 |
| |
ARMSTRONG WORLD INDS INC |
|
|
|
105 |
| |
ARRIS INTERNATIONAL LTD |
|
|
|
238 |
| |
ARROW ELECTR INC |
|
|
|
349 |
| |
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Common stock - continued |
|
|
|
|
|
ASHLAND GLOBAL HLDGS INC |
|
|
|
365 |
|
ASPEN INSURANCE HLDGS |
|
|
|
175 |
|
ASSOCTD BANC-CORP |
|
|
|
200 |
|
ASSURANT INC |
|
|
|
284 |
|
ASSURED GUARANTY LTD |
|
|
|
271 |
|
ATMOS ENERGY CORP |
|
|
|
403 |
|
AUTODESK INC |
|
|
|
152 |
|
AUTONATION INC |
|
|
|
103 |
|
AVALONBAY CMNTYS REIT |
|
|
|
1,306 |
|
AVANGRID INC |
|
|
|
114 |
|
AVERY DENNISON CORP |
|
|
|
18 |
|
AVNET INC |
|
|
|
329 |
|
AXIS CAPITAL HOLDINGS LTD |
|
|
|
322 |
|
BAKER HUGHES INC |
|
|
|
1,530 |
|
BANKUNITED INC |
|
|
|
199 |
|
BED BATH & BEYOND INC |
|
|
|
292 |
|
BEMIS CO INC |
|
|
|
205 |
|
BERKLEY W R CORP |
|
|
|
344 |
|
BEST BUY INC |
|
|
|
636 |
|
BIO RAD LABS INC |
|
|
|
201 |
|
BK HAW CORP |
|
|
|
201 |
|
BLOCK H & R INC |
|
|
|
256 |
|
BOK FINL CORP |
|
|
|
115 |
|
BOOZ ALLEN HAMILTON HLDG CORP |
|
|
|
12 |
|
BORG WARNER INC |
|
|
|
404 |
|
BRANDYWINE RLTY TR |
|
|
|
151 |
|
BRIXMOR PPTY GROUP INC |
|
|
|
253 |
|
BROCADE COMMUNICATIONS SYS INC |
|
|
|
270 |
|
BROOKDALE SR LIVING INC |
|
|
|
121 |
|
BROWN & BROWN INC |
|
|
|
266 |
|
BROWN FORMAN CORP |
|
|
|
7 |
|
BROWN-FORMAN INC CL B NON-VTG |
|
|
|
26 |
|
BRUNSWICK CORP |
|
|
|
47 |
|
BSTN PPTYS INC |
|
|
|
858 |
|
BUNGE LTD |
|
|
|
539 |
|
BURLINGTON STORES INC |
|
|
|
136 |
|
CA INC |
|
|
|
498 |
|
CABELAS INC |
|
|
|
136 |
|
CABOT CORP |
|
|
|
164 |
|
CABOT OIL & GAS CORP |
|
|
|
169 |
|
CALATLANTIC GROUP INC |
|
|
|
120 |
|
CALPINE CORP |
|
|
|
222 |
|
CAMDEN PPTY TR |
|
|
|
386 |
|
CARE CAP PPTYS INC |
|
|
|
102 |
|
CARLISLE COMPANIES INC |
|
|
|
262 |
|
CELANESE CORP |
|
|
|
567 |
|
CENTENE CORP |
|
|
|
133 |
|
CENTERPOINT ENERGY INC |
|
|
|
571 |
|
CENTURYLINK INC |
|
|
|
687 |
|
CF INDS HLDGS INC |
|
|
|
396 |
|
CHENIERE ENERGY INC |
|
|
|
444 |
|
CHESAPEAKE ENERGY CORP |
|
|
|
208 |
|
CHICAGO BRDG & IRON CO N V |
|
|
|
176 |
|
CHIMERA INVT CORP |
|
|
|
169 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Common stock - continued |
|
|
|
|
|
CHOICE HOTELS INTL INC |
|
|
|
30 |
|
CIMAREX ENERGY CO |
|
|
|
574 |
|
CIN FNCL CORP |
|
|
|
610 |
|
CIT GROUP INC |
|
|
|
456 |
|
CITIZENS FINL GROUP INC |
|
|
|
596 |
|
CLEAN HBRS INC |
|
|
|
143 |
|
CLEAR CHANNEL OUTDOOR HLDGS INC |
|
|
|
4 |
|
CLOROX CO |
|
|
|
123 |
|
CMS ENERGY CORP |
|
|
|
622 |
|
CNA FNCL CORP |
|
|
|
62 |
|
COACH INC |
|
|
|
425 |
|
COLFAX CORP |
|
|
|
187 |
|
COLONY NORTHSTAR |
|
|
|
145 |
|
COLUMBIA PPTY TR INC |
|
|
|
142 |
|
COM ALCOA CORPORATION |
|
|
|
223 |
|
COMERICA INC |
|
|
|
638 |
|
COMM BANCSHARES INC |
|
|
|
269 |
|
COMMERCEHUB ICOMMERCEHUB INC |
|
|
|
18 |
|
COMMERCEHUB INC |
|
|
|
8 |
|
COMPASS MINERALS INTL INC |
|
|
|
141 |
|
CONAGRA BRANDS INC |
|
|
|
193 |
|
CONCHO RES INC |
|
|
|
1,004 |
|
CONS EDISON INC |
|
|
|
1,206 |
|
CONSOL ENERGY INC |
|
|
|
224 |
|
CONTINENTAL RES INC |
|
|
|
132 |
|
COOPER COS INC |
|
|
|
100 |
|
COPA HOLDINGS SA |
|
|
|
151 |
|
CORECIVIC INC |
|
|
|
151 |
|
CORELOGIC INC |
|
|
|
73 |
|
CORP OFFICE PPTYS TR |
|
|
|
157 |
|
COTY INC |
|
|
|
425 |
|
CRANE CO |
|
|
|
187 |
|
CREE INC |
|
|
|
91 |
|
CST BRANDS INC |
|
|
|
191 |
|
CUBESMART |
|
|
|
83 |
|
CULLEN / FROST BANKERS INC |
|
|
|
253 |
|
CUMMINS INC |
|
|
|
1,160 |
|
CYPRESS SEMICONDUCTOR CORP |
|
|
|
189 |
|
CYRUSONE INC |
|
|
|
20 |
|
D R HORTON INC |
|
|
|
225 |
|
DAVITA INC |
|
|
|
352 |
|
DCT INDL TR INC |
|
|
|
234 |
|
DDR CORP |
|
|
|
254 |
|
DENTSPLY SIRONA INC |
|
|
|
714 |
|
DEVON ENERGY CORP |
|
|
|
1,169 |
|
DIAMOND OFFSHORE DRILLING INC |
|
|
|
63 |
|
DIAMONDBACK ENERGY INC |
|
|
|
320 |
|
DICKS SPORTING GOODS INC |
|
|
|
56 |
|
DIGITAL RLTY TR INC |
|
|
|
251 |
|
DILLARDS INC |
|
|
|
61 |
|
DISCOVERY COMMUNICATIONS INC |
|
|
|
23 |
|
DISCOVERY COMMUNICATIONS INC |
|
|
|
15 |
|
DOLBY LABORATORIES INC |
|
|
|
122 |
|
DOMTAR CORP |
|
|
|
130 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Common stock - continued |
|
|
|
|
|
DONALDSON INC |
|
|
|
21 |
|
DONNELLEY FINL SOLUTIONS INC |
|
|
|
10 |
|
DONNELLEY R R & SONS CO |
|
|
|
19 |
|
DOUGLAS EMMETT INC |
|
|
|
276 |
|
DOVER CORP |
|
|
|
617 |
|
DRIL-QUIP INC |
|
|
|
122 |
|
DTE ENERGY CO |
|
|
|
947 |
|
DUKE RLTY CORP |
|
|
|
495 |
|
DUN & BRADSTREET CORP |
|
|
|
140 |
|
DXC TECHNOLOGY CO |
|
|
|
442 |
|
E TRADE FINL CORP |
|
|
|
520 |
|
EAST WEST BANCORP INC |
|
|
|
392 |
|
EASTMAN CHEM CO |
|
|
|
597 |
|
ECHOSTAR CORPORATION |
|
|
|
125 |
|
EDGEWELL PERS CARE CO |
|
|
|
233 |
|
EDISON INTL |
|
|
|
1,225 |
|
EMPIRE ST RLTY TR INC |
|
|
|
49 |
|
ENDO INTL LTD |
|
|
|
179 |
|
ENDURANCE SPECIALTY |
|
|
|
318 |
|
ENERGEN CORP |
|
|
|
301 |
|
ENERGIZER HLDGS INC |
|
|
|
101 |
|
ENSCO PLC |
|
|
|
156 |
|
ENTERGY CORP |
|
|
|
707 |
|
ENVISION HEALTHCARE CORP |
|
|
|
115 |
|
EPR PPTYS COM SH BEN INT |
|
|
|
241 |
|
EQT CORP |
|
|
|
605 |
|
EQUITY COMWLTH |
|
|
|
200 |
|
ERIE INDTY CO |
|
|
|
37 |
|
ESSEX PPTY TR REIT |
|
|
|
475 |
|
EVEREST RE GROUP |
|
|
|
487 |
|
EVERSOURCE ENERGY |
|
|
|
943 |
|
EXPEDITORS INTL WASH INC |
|
|
|
151 |
|
EXTENDED STAY AMER INC |
|
|
|
57 |
|
EXTRACTION OIL & GAS INC |
|
|
|
34 |
|
FIDELITY NATL FINL INC |
|
|
|
479 |
|
FIDELITY NATL INFORMATION SVCS INC |
|
|
|
569 |
|
FIREEYE INC |
|
|
|
75 |
|
FIRST AMERN FINL CORP |
|
|
|
208 |
|
FIRST HAWAIIAN INC |
|
|
|
39 |
|
FIRST REP BK SAN FRANCISCO CALIF |
|
|
|
142 |
|
FIRST SOLAR INC |
|
|
|
129 |
|
FIRSTENERGY CORP |
|
|
|
709 |
|
FITBIT INC |
|
|
|
9 |
|
FLIR SYS INC |
|
|
|
268 |
|
FLOWERS FOODS INC |
|
|
|
15 |
|
FLOWSERVE CORP |
|
|
|
131 |
|
FLUOR CORP |
|
|
|
394 |
|
FMC CORP |
|
|
|
80 |
|
FOOT LOCKER INC |
|
|
|
54 |
|
FOREST CITY RLTY TR INC |
|
|
|
257 |
|
FRANKS INTERNATIONAL |
|
|
|
22 |
|
FREEPORT-MCMORAN INC |
|
|
|
736 |
|
FRONTIER COMMUNICATIONS CORP |
|
|
|
214 |
|
GALLAGHER ARTHUR J & CO |
|
|
|
153 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Common stock - continued |
|
|
|
|
|
GAMESTOP CORP |
|
|
|
137 |
|
GAP INC |
|
|
|
252 |
|
GARMIN LTD |
|
|
|
292 |
|
GENESEE & WYO INC |
|
|
|
213 |
|
GENTEX CORP |
|
|
|
107 |
|
GENUINE PARTS CO |
|
|
|
41 |
|
GGP INC |
|
|
|
773 |
|
GOODYEAR TIRE & RUBBER CO |
|
|
|
441 |
|
GRACE W R & CO |
|
|
|
114 |
|
GRAHAM HLDGS CO |
|
|
|
119 |
|
GRAPHIC PACKAGING HLDG CO |
|
|
|
65 |
|
GREAT PLAINS ENERGY INC |
|
|
|
317 |
|
GULFPORT ENERGY CORP |
|
|
|
144 |
|
HAIN CELESTIAL GROUP INC |
|
|
|
56 |
|
HANOVER INS GROUP INC |
|
|
|
204 |
|
HARMAN INTL |
|
|
|
228 |
|
HARRIS CORP |
|
|
|
686 |
|
HARTFORD FINL SVCS GROUP INC |
|
|
|
1,003 |
|
HAWAIIAN ELEC INDS INC |
|
|
|
189 |
|
HCP INC |
|
|
|
747 |
|
HEALTHCARE TR AMER INC |
|
|
|
58 |
|
HELMERICH & PAYNE INC |
|
|
|
403 |
|
HERC HLDGS INC |
|
|
|
40 |
|
HERTZ GLOBAL HLDGS INC |
|
|
|
67 |
|
HESS CORP |
|
|
|
943 |
|
HIGHWOODS PPTYS INC |
|
|
|
265 |
|
HILL-ROM HLDGS INC |
|
|
|
12 |
|
HILTON WORLDWIDE |
|
|
|
94 |
|
HOLLYFRONTIER CORP |
|
|
|
287 |
|
HORMEL FOODS CORP |
|
|
|
66 |
|
HOSPITALITY PPTYS TR |
|
|
|
275 |
|
HOST HOTELS & RESORTS INC |
|
|
|
745 |
|
HOWARD HUGHES CORP |
|
|
|
224 |
|
HUBBELL INC |
|
|
|
123 |
|
HUNTINGTON BANCSHARES INC |
|
|
|
764 |
|
HUNTINGTON INGALLS INDS INC |
|
|
|
77 |
|
HUNTSMAN CORP |
|
|
|
201 |
|
HYATT HOTELS CORP |
|
|
|
91 |
|
IAC / INTERACTIVECORP COM |
|
|
|
55 |
|
IDEX CORP |
|
|
|
24 |
|
INGERSOLL-RAND PLC |
|
|
|
517 |
|
INGREDION INC |
|
|
|
140 |
|
INTERACTIVE BROKERS GROUP INC |
|
|
|
110 |
|
INTERNATIONAL GAME TECHNOLOGY |
|
|
|
128 |
|
INTL PAPER CO |
|
|
|
1,169 |
|
INVESCO LTD |
|
|
|
558 |
|
IPG PHOTONICS CORP |
|
|
|
28 |
|
ITT INC |
|
|
|
185 |
|
JABIL CIRCUIT INC |
|
|
|
235 |
|
JACOBS ENGR GROUP INC |
|
|
|
367 |
|
JETBLUE AWYS CORP |
|
|
|
359 |
|
JOHNSON CTLS INTL PLC |
|
|
|
1,594 |
|
JONES LANG LASALLE INC |
|
|
|
246 |
|
JUNIPER NETWORKS INC |
|
|
|
567 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Common stock - continued |
|
|
|
|
|
JUNO THERAPEUTICS INC |
|
|
|
6 |
|
KBR INC |
|
|
|
127 |
|
KELLOGG CO |
|
|
|
77 |
|
KEYCORP |
|
|
|
1,058 |
|
KEYSIGHT TECHNOLOGIES INC |
|
|
|
338 |
|
KILROY RLTY CORP |
|
|
|
356 |
|
KIMCO RLTY CORP |
|
|
|
545 |
|
KIRBY CORP |
|
|
|
187 |
|
KOHLS CORP |
|
|
|
490 |
|
KOSMOS ENERGY LTD |
|
|
|
56 |
|
KS CY SOUTHN |
|
|
|
491 |
|
L BRANDS INC |
|
|
|
703 |
|
L3 TECHNOLOGIES |
|
|
|
627 |
|
LAB CORP AMER HLDGS |
|
|
|
390 |
|
LAM RESH CORP |
|
|
|
181 |
|
LAMB WESTON HLDGS INC |
|
|
|
62 |
|
LAREDO PETROLEUM INC |
|
|
|
110 |
|
LEAR CORP |
|
|
|
92 |
|
LEGG MASON INC |
|
|
|
168 |
|
LEIDOS HLDGS INC |
|
|
|
178 |
|
LENNAR CORP |
|
|
|
201 |
|
LENNAR CORP |
|
|
|
8 |
|
LENNOX INTL INC |
|
|
|
23 |
|
LEUCADIA NATL CORP |
|
|
|
411 |
|
LEVEL 3 COMMUNICATIONS INC |
|
|
|
885 |
|
LIBERTY BROADBAND CORP |
|
|
|
100 |
|
LIBERTY BROADBAND CORP |
|
|
|
411 |
|
LIBERTY EXPEDIA HLDGS INC |
|
|
|
91 |
|
LIBERTY INTERACTIVE CORP |
|
|
|
127 |
|
LIBERTY INTERACTIVE CORPORATION QVC GROUP |
|
|
|
206 |
|
LIBERTY MEDIA CORP SIRIUSXM GROUP SER A |
|
|
|
166 |
|
LIBERTY MEDIA CORP SIRIUSXM GROUP SER C |
|
|
|
335 |
|
LIBERTY PPTY TR |
|
|
|
311 |
|
LIFE STORAGE INC |
|
|
|
74 |
|
LIFEPOINT HEALTH INC |
|
|
|
114 |
|
LINCOLN ELEC HLDGS INC |
|
|
|
93 |
|
LINCOLN NATL CORP |
|
|
|
657 |
|
LIONS GATE ENTMT CORP |
|
|
|
21 |
|
LIONS GATE ENTMT CORP VOTING SHARES CL A |
|
|
|
23 |
|
LIVE NATION ENTERTAINMENT INC |
|
|
|
82 |
|
LOEWS CORP |
|
|
|
704 |
|
LPL FINL HLDGS INC |
|
|
|
139 |
|
LSC COMMUNICATIONS INC |
|
|
|
13 |
|
M & T BK CORP |
|
|
|
1,256 |
|
MACERICH CO REIT |
|
|
|
546 |
|
MACQUARIE INFRASTRUCTURE CORP |
|
|
|
328 |
|
MACYS INC |
|
|
|
593 |
|
MADISON SQUARE GARDEN CO |
|
|
|
159 |
|
MALLINCKRODT PLC |
|
|
|
294 |
|
MANPOWERGROUP INC |
|
|
|
319 |
|
MARATHON OIL CORP |
|
|
|
788 |
|
MARATHON PETE CORP |
|
|
|
1,424 |
|
MARKEL CORP HOLDING CO |
|
|
|
663 |
|
MARRIOTT INTL INC |
|
|
|
352 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Common stock - continued |
|
|
|
|
|
MARTIN MARIETTA MATLS INC |
|
|
|
73 |
|
MARVELL TECH GROUP |
|
|
|
301 |
|
MASCO CORP |
|
|
|
196 |
|
MDU RES GROUP INC |
|
|
|
301 |
|
MEAD JOHNSON NUTRITION COM |
|
|
|
455 |
|
MEDNAX INC |
|
|
|
98 |
|
MERCURY GEN CORP |
|
|
|
90 |
|
MFA FINL INC |
|
|
|
150 |
|
MGM RESORTS INTERNATIONAL |
|
|
|
668 |
|
MICHAELS COS INC |
|
|
|
23 |
|
MICRON TECH INC |
|
|
|
1,220 |
|
MID-AMER APT CMNTYS INC |
|
|
|
593 |
|
MLP LAZARD LTD |
|
|
|
245 |
|
MOHAWK INDS INC |
|
|
|
137 |
|
MOLSON COORS BREWING |
|
|
|
899 |
|
MOODYS CORP |
|
|
|
91 |
|
MOSAIC CO/THE |
|
|
|
551 |
|
MOTOROLA SOLUTIONS INC |
|
|
|
690 |
|
MSC INDL DIRECT INC |
|
|
|
128 |
|
MURPHY OIL CORP |
|
|
|
274 |
|
MURPHY USA INC |
|
|
|
46 |
|
NABORS INDUSTRIES |
|
|
|
245 |
|
NASDAQ INC |
|
|
|
403 |
|
NATIONAL INSTRS CORP |
|
|
|
35 |
|
NATIONAL OILWELL VARCO |
|
|
|
759 |
|
NATIONAL RETAIL PPTYS INC |
|
|
|
341 |
|
NATL FUEL GAS CO |
|
|
|
226 |
|
NAVIENT CORP |
|
|
|
266 |
|
NETAPP INC |
|
|
|
550 |
|
NEW YORK CMNTY BANCORP INC |
|
|
|
406 |
|
NEWFIELD EXPLORATION |
|
|
|
322 |
|
NEWMARKET CORP |
|
|
|
11 |
|
NEWMONT MINING CORP |
|
|
|
974 |
|
NEWS CORP |
|
|
|
235 |
|
NEWS CORP |
|
|
|
78 |
|
NIELSEN HOLDINGS PLC |
|
|
|
175 |
|
NISOURCE INC |
|
|
|
383 |
|
NOBLE CORP PLC |
|
|
|
78 |
|
NOBLE ENERGY INC |
|
|
|
870 |
|
NORTHERN TR CORP |
|
|
|
980 |
|
NORWEGIAN CRUISE LINE HLDGS LTD |
|
|
|
331 |
|
NRG ENERGY INC |
|
|
|
205 |
|
NU SKIN ENTERPRISES INC |
|
|
|
100 |
|
NUANCE COMMUNICATIONS INC |
|
|
|
41 |
|
NUCOR CORP |
|
|
|
1,016 |
|
NUTANIX INC |
|
|
|
5 |
|
OCEANEERING INTL INC |
|
|
|
147 |
|
OGE ENERGY CORP |
|
|
|
358 |
|
OLD DOMINION FGHT LINE INC |
|
|
|
118 |
|
OLD REP INTL CORP |
|
|
|
249 |
|
OMEGA HEALTHCARE INVS INC |
|
|
|
192 |
|
ON SEMICONDUCTOR CORP |
|
|
|
256 |
|
ONEMAIN HLDGS INC |
|
|
|
64 |
|
OPKO HEALTH INC |
|
|
|
13 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Common stock - continued |
|
|
|
|
|
ORBITAL ATK INC |
|
|
|
277 |
|
OSHKOSH CORPORATION |
|
|
|
254 |
|
OUTFRONT MEDIA INC |
|
|
|
153 |
|
OWENS CORNING |
|
|
|
319 |
|
PACCAR INC |
|
|
|
1,073 |
|
PACWEST BANCORP |
|
|
|
347 |
|
PANDORA MEDIA INC |
|
|
|
21 |
|
PARAMOUNT GROUP INC |
|
|
|
153 |
|
PARKER-HANNIFIN CORP |
|
|
|
1,004 |
|
PARSLEY ENERGY INC |
|
|
|
282 |
|
PATHEON N V |
|
|
|
20 |
|
PATTERSON-UTI ENERGY INC |
|
|
|
206 |
|
PBF ENERGY INC |
|
|
|
146 |
|
PENNEY J.C CO INC |
|
|
|
136 |
|
PENSKE AUTOMOTIVE GROUP INC |
|
|
|
108 |
|
PENTAIR PLC |
|
|
|
501 |
|
PEOPLES UTD FINL INC |
|
|
|
322 |
|
PERKINELMER INC |
|
|
|
242 |
|
PERRIGO COMPANY LIMITED |
|
|
|
617 |
|
PIEDMONT OFFICE REALTY |
|
|
|
161 |
|
PILGRIMS PRIDE CORP |
|
|
|
49 |
|
PINNACLE FOODS INC |
|
|
|
333 |
|
PINNACLE W. CAP CORP |
|
|
|
466 |
|
PLATFORM SPECIALTY PRODS CORP |
|
|
|
103 |
|
POPULAR INC |
|
|
|
243 |
|
POST HLDGS INC |
|
|
|
117 |
|
PPL CORP COM |
|
|
|
1,242 |
|
PREMIER INC |
|
|
|
54 |
|
PRINCIPAL FINL GROUP INC |
|
|
|
831 |
|
PROASSURANCE CORP |
|
|
|
157 |
|
PROGRESSIVE CORP |
|
|
|
1,003 |
|
PROLOGIS INC |
|
|
|
1,482 |
|
PTC INC |
|
|
|
156 |
|
PUB SERVICE ENTERPRISE GROUP INC |
|
|
|
1,192 |
|
PULTE GROUP INC |
|
|
|
241 |
|
PVH CORP |
|
|
|
391 |
|
QEP RES INC |
|
|
|
238 |
|
QIAGEN |
|
|
|
344 |
|
QORVO INC |
|
|
|
328 |
|
QUALITY CARE PPTYS INC |
|
|
|
77 |
|
QUANTA SVCS INC |
|
|
|
194 |
|
QUEST DIAGNOSTICS INC |
|
|
|
699 |
|
QUINTILES IMS HOLDINGS INC |
|
|
|
116 |
|
RALPH LAUREN CORP |
|
|
|
259 |
|
RANGE RES CORP |
|
|
|
378 |
|
RAYMOND JAMES FNCL INC |
|
|
|
471 |
|
RAYONIER INC REIT |
|
|
|
173 |
|
REALOGY HLDGS CORP |
|
|
|
198 |
|
REALTY INCOME CORP |
|
|
|
797 |
|
REGAL BELOIT CORP |
|
|
|
164 |
|
REGAL ENTMT GROUP |
|
|
|
66 |
|
REGENCY CENTERS CORPORATION |
|
|
|
149 |
|
REGENCY CTRS CORP |
|
|
|
317 |
|
REGIONS FINL CORP |
|
|
|
978 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Common stock - continued |
|
|
|
|
|
REINSURANCE GROUP AMER INC |
|
|
|
432 |
|
RELIANCE STL & ALUM CO |
|
|
|
298 |
|
RENAISSANCE RE HLDGS LTD |
|
|
|
311 |
|
REPUBLIC SVCS INC |
|
|
|
723 |
|
RETAIL PPTYS AMER INC |
|
|
|
193 |
|
RICE ENERGY INC |
|
|
|
175 |
|
ROCKWELL AUTOMATION |
|
|
|
194 |
|
ROPER TECHNOLOGIES, INC |
|
|
|
481 |
|
ROWAN COMPANIES PLC |
|
|
|
128 |
|
ROYAL CARIBBEAN CRUISES |
|
|
|
742 |
|
ROYAL GOLD INC |
|
|
|
205 |
|
RPC INC |
|
|
|
64 |
|
RYDER SYS INC |
|
|
|
216 |
|
SANTANDER CONSUMER USA HLDGS INC |
|
|
|
78 |
|
SBA |
|
|
|
248 |
|
SCANA CORP |
|
|
|
513 |
|
SCOTTS MIRACLE-GRO |
|
|
|
17 |
|
SEMPRA ENERGY INC |
|
|
|
1,352 |
|
SENIOR HSG PPTYS |
|
|
|
209 |
|
SIGNATURE BK NY N Y |
|
|
|
173 |
|
SIGNET JEWELERS LTD |
|
|
|
28 |
|
SKYWORKS SOLUTIONS INC |
|
|
|
64 |
|
SL GREEN RLTY CORP |
|
|
|
563 |
|
SLM CORP |
|
|
|
254 |
|
SM ENERGY CO |
|
|
|
179 |
|
SMUCKER J M CO |
|
|
|
797 |
|
SNAP-ON INC |
|
|
|
142 |
|
SONOCO PROD CO |
|
|
|
283 |
|
SOUTHN COPPER CORP |
|
|
|
81 |
|
SPIRIT AEROSYSTEMS HLDGS INC |
|
|
|
185 |
|
SPIRIT AIRLS INC |
|
|
|
223 |
|
SPIRIT RLTY CAP INC |
|
|
|
282 |
|
SPRINT CORP |
|
|
|
344 |
|
SS&C TECHNOLOGIES HLDGS INC |
|
|
|
20 |
|
STANLEY BLACK & DECKER INC |
|
|
|
810 |
|
STAPLES INC |
|
|
|
314 |
|
STARWOOD PROPERTY TRUST INC |
|
|
|
295 |
|
STEEL DYNAMICS INC |
|
|
|
382 |
|
STERICYCLE INC |
|
|
|
18 |
|
STORE CAPITAL CORPORATION |
|
|
|
198 |
|
SUN COMMUNITIES INC |
|
|
|
277 |
|
SUN TR BANKS INC |
|
|
|
1,478 |
|
SUNPOWER CORP |
|
|
|
19 |
|
SUPERIOR ENERGY SVCS INC |
|
|
|
135 |
|
SVB FINANCIAL GROUP |
|
|
|
126 |
|
SYMANTEC CORP |
|
|
|
676 |
|
SYNCHRONY FINL |
|
|
|
1,630 |
|
SYNOPSYS INC |
|
|
|
433 |
|
SYNOVUS FINL CORP |
|
|
|
276 |
|
T ROWE PRICE GROUP INC |
|
|
|
232 |
|
TAHOE RES INC |
|
|
|
150 |
|
TANGER FACTORY OUTLET CTRS INC |
|
|
|
16 |
|
TARGA RES CORP |
|
|
|
496 |
|
TAUBMAN CTRS INC |
|
|
|
117 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Common stock - continued |
|
|
|
|
|
TCF FNCL CORP |
|
|
|
165 |
|
TD AMERITRADE HLDG CORP |
|
|
|
65 |
|
TECHNIPFMC INC |
|
|
|
430 |
|
TEGNA INC |
|
|
|
252 |
|
TELEFLEX INC |
|
|
|
310 |
|
TELEPHONE & DATA SYS INC |
|
|
|
147 |
|
TERADYNE INC |
|
|
|
279 |
|
TEREX CORP |
|
|
|
178 |
|
TESORO CORP |
|
|
|
561 |
|
TEXTRON INC |
|
|
|
485 |
|
TFS FINL CORP |
|
|
|
60 |
|
TIFFANY & CO |
|
|
|
455 |
|
TIMKEN CO |
|
|
|
149 |
|
TOLL BROS INC |
|
|
|
136 |
|
TORCHMARK CORP |
|
|
|
471 |
|
TRANSOCEAN LTD |
|
|
|
275 |
|
TREEHOUSE FOODS INC |
|
|
|
144 |
|
TRIBUNE MEDIA COMPANY |
|
|
|
133 |
|
TRIMBLE INC |
|
|
|
87 |
|
TRINITY IND INC |
|
|
|
225 |
|
TWILIO INC |
|
|
|
8 |
|
TWITTER INC |
|
|
|
66 |
|
TWO HBRS INVT CORP |
|
|
|
160 |
|
TYSON FOODS INC |
|
|
|
514 |
|
U.S. CELLULAR CORP |
|
|
|
30 |
|
UDR INC |
|
|
|
520 |
|
UGI CORP |
|
|
|
426 |
|
UNITED CONTL HLDGS INC |
|
|
|
1,241 |
|
UNITED RENTALS INC |
|
|
|
74 |
|
UNITED STS STL CORP |
|
|
|
274 |
|
UNITED THERAPEUTICS CORP |
|
|
|
243 |
|
UNITI GROUP |
|
|
|
165 |
|
UNUM GROUP |
|
|
|
562 |
|
UNVL HEALTH SERVICES INC |
|
|
|
369 |
|
URBAN OUTFITTERS INC |
|
|
|
29 |
|
USG CORP |
|
|
|
135 |
|
VALIDUS HOLDING LTD |
|
|
|
220 |
|
VALMONT INDS INC |
|
|
|
32 |
|
VALVOLINE INC |
|
|
|
35 |
|
VECTREN CORP |
|
|
|
234 |
|
VENTAS INC |
|
|
|
780 |
|
VEREIT INC |
|
|
|
440 |
|
VIACOM INC |
|
|
|
2 |
|
VIACOM INC |
|
|
|
78 |
|
VISTA OUTDOOR INC |
|
|
|
100 |
|
VORNADO RLTY TR |
|
|
|
963 |
|
VOYA FINL INC |
|
|
|
431 |
|
VULCAN MATERIALS CO |
|
|
|
63 |
|
VWR CORP |
|
|
|
99 |
|
W P CAREY INC |
|
|
|
330 |
|
WEATHERFORD INTERNATIONAL LTD |
|
|
|
262 |
|
WEC ENERGY GROUP INC |
|
|
|
996 |
|
WEINGARTEN RLTY INVS |
|
|
|
222 |
|
WELBILT INC |
|
|
|
75 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Common stock - continued |
|
|
|
|
|
WELLCARE HLTH PLANS INC |
|
|
|
25 |
|
WELLTOWER INC |
|
|
|
1,286 |
|
WENDYS CO |
|
|
|
67 |
|
WESCO INTL |
|
|
|
171 |
|
WESTAR ENERGY INC |
|
|
|
428 |
|
WESTERN ALLIANCE BANCORPORATION |
|
|
|
108 |
|
WESTLAKE CHEM CORP |
|
|
|
114 |
|
WESTN DIGITAL CORP |
|
|
|
1,031 |
|
WESTROCK CO |
|
|
|
683 |
|
WEYERHAEUSER CO |
|
|
|
1,199 |
|
WHIRLPOOL CORP |
|
|
|
653 |
|
WHITE MOUNTAINS INSURANCE GROUP |
|
|
|
191 |
|
WHITING PETE CORP |
|
|
|
131 |
|
WHOLE FOODS MKT INC |
|
|
|
439 |
|
WILEY JOHN & SONS INC |
|
|
|
129 |
|
WILLIAMS CO INC |
|
|
|
961 |
|
WORLD FUEL SERVICE |
|
|
|
168 |
|
WPX ENERGY INC |
|
|
|
262 |
|
WYNN RESORTS LTD |
|
|
|
31 |
|
XCEL ENERGY INC |
|
|
|
1,113 |
|
XEROX CORP |
|
|
|
472 |
|
XILINX INC |
|
|
|
562 |
|
XL GROUP LTD |
|
|
|
351 |
|
XYLEM INC |
|
|
|
226 |
|
YELP INC |
|
|
|
30 |
|
ZEBRA TECHNOLOGIES CORP |
|
|
|
42 |
|
ZILLOW GROUP INC |
|
|
|
29 |
|
ZILLOW GROUP INC |
|
|
|
64 |
|
ZIMMER BIOMET HLDGS INC |
|
|
|
481 |
|
ZIONS BANCORP |
|
|
|
465 |
|
ZYNGA INC |
|
|
|
100 |
|
Total Common stock |
|
|
|
2,639,909 |
|
|
|
|
|
|
|
Mutual funds |
|
|
|
|
|
AMERICAN FUNDS EUROPACIFIC GROWTH FUND |
|
|
|
253,591 |
|
AMERICAN FUNDS GROWTH FUND OF AMERICA |
|
|
|
513,098 |
|
AMERICAN FUNDS INVESTMENT COMPANY OF AMERICA |
|
|
|
253,042 |
|
AMERICAN FUNDS WASHINGTON MUTUAL INVESTORS FUND |
|
|
|
166,285 |
|
PIMCO ALL ASSET FUND |
|
|
|
85,396 |
|
Total Mutual funds |
|
|
|
1,271,412 |
|
|
|
|
|
|
|
Collective trust funds |
|
|
|
|
|
BLACKROCK INTERNATIONAL OPPORTUNITIES FUND |
|
|
|
62,735 |
|
*NORTHERN TRUST COLLECTIVE WORLD ex-U.S. INDEX FUND |
|
|
|
77,576 |
|
*NORTHERN TRUST COLLECTIVE ACWI ex-U.S. INDEX FUND |
|
|
|
1,456 |
|
PIMCO TOTAL RETURN COLLECTIVE TRUST FUND |
|
|
|
175,503 |
|
SSGA RUSSELL SMALL/MID CAP INDEX FUND CLASS K |
|
|
|
303,567 |
|
SSGA S&P 500 INDEX FUND CLASS K |
|
|
|
449,968 |
|
SSGA U.S. BOND INDEX FUND CLASS K |
|
|
|
5,825 |
|
SSGA TARGET RETIREMENT 2015 |
|
|
|
38,798 |
|
SSGA TARGET RETIREMENT 2020 |
|
|
|
127,292 |
|
SSGA TARGET RETIREMENT 2025 |
|
|
|
123,245 |
|
SSGA TARGET RETIREMENT 2030 |
|
|
|
104,630 |
|
SSGA TARGET RETIREMENT 2035 |
|
|
|
73,480 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Collective trust funds - continued |
|
|
|
|
|
SSGA TARGET RETIREMENT 2040 |
|
|
|
47,070 |
|
SSGA TARGET RETIREMENT 2045 |
|
|
|
28,265 |
|
SSGA TARGET RETIREMENT 2050 |
|
|
|
12,518 |
|
SSGA TARGET RETIREMENT 2055 |
|
|
|
3,243 |
|
SSGA TARGET RETIREMENT 2060 |
|
|
|
620 |
|
SSGA TARGET RETIREMENT INCOME |
|
|
|
21,994 |
|
WELLINGTON MID-CAP GROWTH FUND |
|
|
|
78,871 |
|
*NORTHERN TRUST COLLECTIVE SHORT TERM INVESTMENT FUND |
|
|
|
7,665 |
|
Total Collective trust funds |
|
|
|
1,744,321 |
|
|
|
|
|
|
|
Futures contracts |
|
|
|
|
|
FUT MAR 17 EMINI S&P 500 |
|
|
|
224 |
|
FUT MAR 17 IMM EMINI MDCP |
|
|
|
2,986 |
|
EQUITY FUTURES OFFSET - LONG |
|
|
|
(3,210 |
) |
Total Futures contracts |
|
|
|
|
|
|
|
|
|
|
|
Corporate debt |
|
|
|
|
|
ACTAVIS FDG SCS FLTG RT 2.19956% DUE 03-12-2018 |
|
|
|
2,816 |
|
ACTAVIS FDG SCS GTD NT FLTG RATE DUE 03-12-2020 |
|
|
|
2,854 |
|
AERCAP IRELAND CAP 4.625% DUE 10-30-2020 |
|
|
|
1,144 |
|
ANHEUSER-BUSCH FLTG RT 2.294% DUE 02-01-2021 |
|
|
|
1,526 |
|
AT&T INC FLTG RT 1.78956% DUE 03-11-2019 |
|
|
|
3,790 |
|
AT&T INC NT FLTG RATE DUE 06-30-2020 |
|
|
|
1,005 |
|
BABSON CLO 2012 SR SECD NT CL A-1R FLTG 05-15-2023 |
|
|
|
792 |
|
BANCO SANTANDER CHILE MEDIUM TERM SR BK FLT RT 144A 04-11-2017 |
|
|
|
999 |
|
BARCLAYS BANK PLC 6.05% MTN 12/17 |
|
|
|
1,757 |
|
BBCMS TR 2015-SLP FLTG RT 2.10389% DUE 02-15-2028 |
|
|
|
3,717 |
|
BSTN SCIENTIFIC 5.125% DUE 01-12-2017 |
|
|
|
1,501 |
|
CENT CLO 19 CORPSR SECD NT CL A-1A 144A 10-29-2025 |
|
|
|
2,000 |
|
CITIGROUP INC FLTG RT 2.03167% DUE 06-07-2019 |
|
|
|
1,310 |
|
CITIGROUP INC FLTG RT 2.34178% DUE 10-26-2020 |
|
|
|
4,152 |
|
CONOCOPHILLIPS CO NT FLTG RATE DUE 05-15-2022 REG |
|
|
|
990 |
|
COOPERATIEVE RABOBANK UA CASH MEDIUM-TERM NOTES VAR RT DUE 11-29-2049 |
|
|
|
1,358 |
|
CREDIT AGRICOLE S A TRANCHE # TR 00013 VAR DUE 04-15-2019 |
|
|
|
1,707 |
|
CVP CASCADE CLO- NT CL A-1 FLTG 144A 01-16-2026 |
|
|
|
2,696 |
|
DAIMLER FIN NORTH AMER LLC NT FLTG 144A DUE 10-30-2019 |
|
|
|
5,012 |
|
DBS GROUP HLDGS 2.246% DUE 07-16-2019 |
|
|
|
1,005 |
|
DBS GROUP HLDGS FLTG RT .7336% DUE 07-16-2019 |
|
|
|
899 |
|
DEXIA CR LOC NY BRH MED TEM NTS BO TRANCHE # TR 4 VAR 01-11-2017 |
|
|
|
1,000 |
|
EDF S A NT FLTG 144A DUE 01-20-2017 |
|
|
|
1,300 |
|
EL PASO CORP 7% DUE 06-15-2017 |
|
|
|
2,046 |
|
ELECTRICITE DE FRANCE IAM COML PAPER NTS 4/2 CPN 01-09-2017 |
|
|
|
4,999 |
|
GEN MTRS FINL CO 4.75 DUE 08-15-2017 |
|
|
|
408 |
|
GENERAL MOTORS FINL CO 2.4% DUE 04-10-2018 |
|
|
|
501 |
|
GENERAL MOTORS FINL CO FRN 04-10-2018 |
|
|
|
3,018 |
|
GENERAL MTRS FINL CO INC SR NT FLTG RATEDUE 01-15-2020 |
|
|
|
4,244 |
|
GOLDMAN SACHS FLTG RT 2.31317% DUE 04-23-2020 |
|
|
|
4,893 |
|
HBOS PLC FRN LT2 09/17 |
|
|
|
998 |
|
HEWLETT PACKARD ENTERPRISE CO 144A 2.7% DUE 10-05-2017 |
|
|
|
5,028 |
|
HSBC HLDGS PLC FLTG RT 2.64983% DUE 01-05-2022 |
|
|
|
3,056 |
|
HSBC HLDGS PLC FLTG RT 2.71233% DUE 05-25-2021 |
|
|
|
2,451 |
|
HSBC USA INC NEW FLTG RT 1.64372% DUE 11-13-2019 |
|
|
|
1,196 |
|
HYUNDAI CAP SERVICES INC FLTG RT DUE 03-18-2017 |
|
|
|
1,000 |
|
IMPERIAL TOB FIN PLC 2.95% DUE 07-21-2020 |
|
|
|
1,509 |
|
Identity of party involved/ |
|
|
|
Current |
|
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
|
|
|
|
|
|
|
Corporate debt - continued |
|
|
|
|
|
INTESA SANPAOLO S P A 2.375 DUE 01-13-2017 |
|
|
|
5,401 |
|
INTL LEASE FIN 3.875% DUE 04-15-2018 |
|
|
|
1,936 |
|
INTL LEASE FIN 8.75% DUE 03-15-2017 |
|
|
|
2,028 |
|
JAPAN BK INTL COOPERATION GTD BD FLTG ADJ RT 11-13-2018 |
|
|
|
1,696 |
|
JMP CR ADVISORS SER 13-1A CL A FLTG 144A 04-30-2023 |
|
|
|
1,500 |
|
KOOKMIN BK GLOBAL 144A FLT 01-31-2017 |
|
|
|
1,500 |
|
KRAFT HEINZ FOODS 1.6% DUE 06-30-2017 |
|
|
|
1,101 |
|
KVK CLO SER 12-2A CL A 144A FLTG 02-10-2025 |
|
|
|
1,660 |
|
LEASEPLAN CORP N V 2.875% 01-22-2019 |
|
|
|
4,798 |
|
MACQUARIE BK LTD FLTG DUE 07-29-2020 |
|
|
|
5,836 |
|
MACQUARIE BK LTD SR MEDIUM TERM NTS DUE 02-26-2017 |
|
|
|
1,501 |
|
MIZUHO BANK LTD DUE 03-26-2018 |
|
|
|
2,000 |
|
MIZUHO FINL GROUP FLTG RT 2.63567% DUE 04-12-2021 |
|
|
|
2,237 |
|
ML-CFC COML MTG TR 2007-8 MTG PASS THRU CTF-CL A-3 DUE 08-12-2049 |
|
|
|
1,395 |
|
MORGAN STANLEY CAP I TR SER 2015-XLF1 CL A FLTG 08-13-2016 |
|
|
|
1,851 |
|
MORGAN STANLEY SR NT FLTG VAR RT DUE 07-23-2019 |
|
|
|
2,009 |
|
MUFG AMERS HLDGS FLTG RT 1.60817% DUE 02-09-2018 |
|
|
|
998 |
|
NATIONAL GRID FRN EMTN 08/17 |
|
|
|
5,193 |
|
NAVIENT PRIVATE ED LN TR 2015-A CL A-1 144A FLTG RATE 12-15-2021 |
|
|
|
180 |
|
NAVIENT PRIVATE ED LN TR 2015-C NTCL A FLTG 144A VAR RT DUE 01-16-2035 |
|
|
|
2,538 |
|
NAVIENT STUDENT LN TR 2016-5 NT CLA FLTG 144A VAR RT DUE 06-25-2065 |
|
|
|
1,390 |
|
NAVIENT STUDENT LN TR 2016-6 STUDENT LN SER 16-6A CL A1 03-25-2066 |
|
|
|
2,489 |
|
OCEAN TRAILS CLO IV FLTG 3C7 VAR RT DUE 08-13-2025 |
|
|
|
1,500 |
|
PEMEX PROJ FDG MASTER TR GTD NT 5.75% DUE 03-01-2018 |
|
|
|
3,310 |
|
PETROLEOS FLTG RT 3.17844% DUE 07-18-2018 |
|
|
|
1,007 |
|
PETROLEOS MEXICANOS NT 3.5% DUE 07-18-2018 |
|
|
|
1,009 |
|
PIONEER NAT RES CO 6.875% DUE 05-01-2018 |
|
|
|
541 |
|
SANTANDER BANK NA DUE 01-12-2018 |
|
|
|
2,502 |
|
SANTANDER HLDGS FLTG RT 2.504% DUE 11-24-2017 |
|
|
|
2,017 |
|
SANTANDER UK PLC 2% DUE 08-24-2018 |
|
|
|
970 |
|
SANTANDER UK PLC 3.05% DUE 08-23-2018 |
|
|
|
1,524 |
|
SANTANDER UK PLC NT FLTG DUE 09-29-2017 |
|
|
|
1,996 |
|
SARANAC CLO I LTD 2013-1A SR SECD NT CL A-1A VAR RT DUE 10-26-2024 |
|
|
|
2,009 |
|
SHINHAN BK DUE 04-08-2017 |
|
|
|
2,000 |
|
SOCIAL PROFESSIONAL LOAN PROGRAM LL VAR RT DUE 10-25-2036 |
|
|
|
2,392 |
|
SOUTHERN NAT GAS CO SOUTHERN NAT GAS 5.9% DUE 04-01-2017 |
|
|
|
5,557 |
|
SUMITOMO MITSUI BANKING CORP FLTG RATE 3/A2 01-16-2018 |
|
|
|
4,406 |
|
SUMITOMO MITSUI BANKING CORP SR NT FLTG 3/A2 VAR RT DUE 07-23-2018 |
|
|
|
1,003 |
|
TELECOM ITALIA CAP 6.999% DUE 06-04-2018 |
|
|
|
426 |
|
TELEFONICA EMISIONES S A U 6.221 DUE 07-03-2017 |
|
|
|
2,045 |
|
TELEFONICA FLTG RT 1.80622% DUE 06-23-2017 |
|
|
|
2,504 |
|
TIME WARNER CABLE 6.75% DUE 07-01-2018 |
|
|
|
3,737 |
|
UBS AG STAMFORD BRH MEDIUM TERM SR DEP FLTG RT 03-26-2018 |
|
|
|
5,017 |
|
VOLKSWAGEN GROUP AMER FIN LLC GTD NT FLTG 144A 3C7 DUE 05-23-2017 |
|
|
|
3,496 |
|
VOLKSWAGEN GROUP AMER FIN LLC GTD NT 144A 3C7 1.25% DUE 05-23-2017 |
|
|
|
1,697 |
|
WACHOVIA BK COML MTG TR 2007-C31 CL A-5FL FLTG RT DUE 04-15-2047 |
|
|
|
3,987 |
|
WELLS FARGO & CO FLTG RT 2.05678% DUE 07-26-2021 |
|
|
|
5,041 |
|
ZIMMER BIOMET 1.45% DUE 04-01-2017 |
|
|
|
1,500 |
|
ZIMMER BIOMET 2% DUE 04-01-2018 |
|
|
|
1,502 |
|
Total Corporate debt |
|
|
|
196,609 |
|
|
|
|
|
|
|
Government debt |
|
|
|
|
|
GNMA 2016-H17 MTG PASS THRU CTF CL MX FC08-20-2066 |
|
|
|
992 |
|
GNMA 2016-H20 REMIC PASSTHRU CTF CL MX-PT 09-20-2066 |
|
|
|
2,229 |
|
Identity of party involved/ |
|
|
|
Current |
| |
Description of asset/ Rate/ Maturity |
|
Cost (a) |
|
value |
| |
|
|
|
|
|
| |
Government debt - continued |
|
|
|
|
| |
JAPAN FIN ORG MU 2.5% MTN 12/09/2018 |
|
|
|
3,037 |
| |
PUBLIC FIN AUTH WIS HEALTHCARE FACS REV 2.625% 11-01-2019 |
|
|
|
1,994 |
| |
SAUDI ARABIA KINGDOM TRANCHE # TR 1 2.375% DUE 10-26-2021 |
|
|
|
2,622 |
| |
TX ST VAR RT DUE 06-01-2017 |
|
|
|
930 |
| |
UNITED STATES TREAS NTS 1.75 DUE 11-30-2021 |
|
|
|
6,452 |
| |
UNITED STATES TREAS BILLS 03-02-2017 |
|
|
|
195 |
| |
Total Government debt |
|
|
|
18,451 |
| |
|
|
|
|
|
| |
Certificate of deposit |
|
|
|
|
| |
BARCLAYS BK PLC NEW YORK BRH DEP DTD 10-06-2016 1.77085% 11-06-2017 |
|
|
|
3,003 |
| |
BARCLAYS BK PLC NEW YORK BRH INSTL CTF DDTD 09-08-2016 VAR RT DUE 09-08-2017 |
|
|
|
3,005 |
| |
MITSUBISHI UFJ TR & BKG CORP INSTL CTF DEP 766 DTD 09-19-2016 FLTG 09-19-2017 |
|
|
|
3,006 |
| |
MIZUHO BANK LTD/NY DTD 12-12-2016 FLT RT CD DUE 12-12-2017 |
|
|
|
2,501 |
| |
SUMITOMO MITSUI TR BK LTD NY BRH INSTL CCTF DEP DTD 09-16-2016 VAR RT 9-18-2017 |
|
|
|
5,010 |
| |
Total Certificate of deposit |
|
|
|
16,525 |
| |
|
|
|
|
|
| |
Private 40-Act mutual funds |
|
|
|
|
| |
PIMCO Short-Term Floating NAV Portfolio II |
|
|
|
280,090 |
| |
PIMCO Short-Term Portfolio |
|
|
|
29,398 |
| |
Total Private 40-Act mutual funds |
|
|
|
309,488 |
| |
|
|
|
|
|
| |
*Loans to participants, 3.00% to 9.25% |
|
|
|
62,960 |
| |
|
|
|
|
|
| |
|
|
|
|
$ |
6,259,675 |
|
*Represents a party-in-interest transaction. |
|
|
|
|
|
|
|
|
|
|
|
(a) Cost information omitted as all investments are fully participant directed. |
|
|
|
|
|
FINANCIAL STATEMENTS AND
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ABBOTT LABORATORIES STOCK RETIREMENT PLAN (PUERTO RICO)
DECEMBER 31, 2016 and 2015
C O N T E N T S
|
Page |
|
|
3 | |
|
|
FINANCIAL STATEMENTS |
|
|
|
5 | |
|
|
6 | |
|
|
7 | |
|
|
| |
|
|
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR) |
16 |
|
Plan Administrator
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
We have audited the accompanying statements of net assets available for benefits of the Abbott Laboratories Stock Retirement Plan (Puerto Rico) (the Plan) as of December 31, 2016 and 2015, and the related statement of changes in net assets available for benefits for the year ended December 31, 2016. These financial statements are the responsibility of the Plans management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Plans internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Plans internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the net assets available for benefits of the Abbott Laboratories Stock Retirement Plan (Puerto Rico) as of December 31, 2016 and 2015, and the changes in net assets available for benefits for the year ended December 31, 2016 in conformity with accounting principles generally accepted in the United States of America.
The supplemental information in the accompanying schedule of assets (held at end of year) as of December 31, 2016, has been subjected to audit procedures performed in conjunction with the audit of Abbott Laboratories Stock Retirement Plan (Puerto Rico)s financial statements. The supplemental information is presented for purposes of additional analysis and is not a required part of the basic financial statements but include supplemental information required by the
Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. The supplementary information is the responsibility of the Plans management. Our audit procedures included determining whether the supplemental information reconciles to the basic financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information in the accompanying schedule, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information referred to above is fairly stated, in all material respects, in relation to the basic financial statements taken as a whole.
/s/ Grant Thornton LLP |
|
|
|
Chicago, Illinois |
|
June 28, 2017 |
|
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS
December 31, 2016 and 2015
(Dollars in thousands)
|
|
2016 |
|
2015 |
| ||
Assets |
|
|
|
|
| ||
Cash |
|
$ |
30 |
|
$ |
120 |
|
Investments, at fair value |
|
117,058 |
|
113,109 |
| ||
Notes receivable from participants |
|
6,246 |
|
7,362 |
| ||
Due from brokers |
|
14 |
|
|
| ||
Accrued interest income |
|
16 |
|
7 |
| ||
|
|
|
|
|
| ||
Total assets |
|
123,364 |
|
120,598 |
| ||
|
|
|
|
|
| ||
Liabilities |
|
|
|
|
| ||
Cash overdraft |
|
226 |
|
|
| ||
Accrued investment expenses |
|
2 |
|
|
| ||
Due to brokers |
|
97 |
|
118 |
| ||
|
|
|
|
|
| ||
Total liabilities |
|
325 |
|
118 |
| ||
|
|
|
|
|
| ||
NET ASSETS AVAILABLE FOR BENEFITS |
|
$ |
123,039 |
|
$ |
120,480 |
|
The accompanying notes are an integral part of these statements.
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS
Year ended December 31, 2016
(Dollars in thousands)
Additions |
|
|
| |
Contributions |
|
|
| |
Employer |
|
$ |
2,491 |
|
Participant |
|
4,326 |
| |
|
|
|
| |
Total contributions |
|
6,817 |
| |
|
|
|
| |
Investment income (loss) |
|
|
| |
Net depreciation in fair value of investments |
|
(761 |
) | |
Interest and dividends |
|
2,975 |
| |
|
|
|
| |
Net investment income |
|
2,214 |
| |
|
|
|
| |
Interest income on notes receivable from participants |
|
211 |
| |
|
|
|
| |
Total additions |
|
9,242 |
| |
|
|
|
| |
Deductions Benefits paid to participants |
|
6,683 |
| |
|
|
|
| |
NET INCREASE |
|
2,559 |
| |
|
|
|
| |
Net assets available for benefits Beginning of year |
|
120,480 |
| |
|
|
|
| |
End of year |
|
$ |
123,039 |
|
The accompanying notes are an integral part of this statement.
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
December 31, 2016 and 2015
NOTE A - DESCRIPTION OF THE PLAN
The following description of the Abbott Laboratories Stock Retirement Plan (Puerto Rico) (the Plan) provides only general information. Participants should refer to the Plan document for a more complete description of the Plans provisions.
General
The Plan was established January 1, 2013 in conjunction with Abbott Laboratories (Abbott) separating into two publicly traded companies Abbott and AbbVie Inc. (AbbVie). The Plan covers employees of Abbotts selected subsidiaries and affiliates in Puerto Rico (the Company). The employees of the Company had previously participated in the former Abbott Laboratories Stock Retirement Plan (Puerto Rico), which effective January 1, 2013 was renamed AbbVie Puerto Rico Savings Plan (the Former Plan) and sponsorship was assumed by an affiliate of AbbVie.
The Plan is a profit sharing plan containing a cash or deferred arrangement intended to qualify for favorable tax treatment under sections 1081.01 (a) and (d) of the Puerto Rico Internal Revenue Code of 2011, as amended. In addition, the Plan provides an arrangement by which employees may invest in Abbott shares. Employees of the Company may, after meeting certain employment requirements, voluntarily participate in the Plan. The Plans sponsor is Abbott Healthcare (Puerto Rico) Ltd. The Plan is subject to the Employee Retirement Income Security Act of 1974, as amended (ERISA).
As of the year ended December 31, 2015, Mercer Trust Company and Mercer HR Services LLC (collectively, Mercer) were the custodian (Custodian) and record keeper of the Plan. In January 2016, the Plan changed the record keeper of the Plan from Mercer to Hewitt Associates LLC, and the Custodian from Mercer to The Northern Trust Company (Custodian thereafter). Banco Popular de Puerto Rico serves as trustee (Trustee) of the Plan.
Contributions and Vesting
Contributions to the Plan are paid to a trust. The trust is administered by the Trustee. An investment committee (the Committee) may direct the Trustee to establish investment options of the Committees choosing.
Employees are eligible to commence participation in the Plan on any entry date following their date of hire. Eligible employees electing to participate may contribute from 2% to 25% of their eligible earnings, subject to certain limitations. Participants may choose to make their contributions from either pretax earnings or after-tax earnings, or both. Participants who have attained age 50 before the end of the Plan year and who are making the maximum pretax contribution are eligible to make catch-up contributions. Participants pretax contributions are a
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE A - DESCRIPTION OF THE PLAN - Continued
Contributions and Vesting - Continued
pay conversion feature, which is a salary deferral option under the provisions of Section 1081.01(d) of the Puerto Rico Internal Revenue Code of 2011, as amended. Participants may elect to invest their contributions in any or all of the investment options, except for investment options closed to new contributions.
Employer contributions to the Plan are made each payroll period based on the participating employees eligible earnings. The amount of the employer contribution was determined by the Board of Directors of Abbott and, for the year ended December 31, 2016, was 5% of the participants eligible earnings if the participant elected to contribute at least 2% of eligible earnings to the Plan. Employer contributions are invested each pay period according to the participants investment elections.
In connection with the January 1, 2013 separation of Abbott into two publicly traded companies, Abbott shareholders received as a tax-free distribution of one share of AbbVie stock for every share of Abbott held as of the close of business on December 12, 2012, the record date for the distribution. Plan participants may continue to hold the AbbVie stock they received from the distribution that transferred from the Former Plan into their Plan accounts; however, they may not make new contributions or transfer existing contributions or earnings to purchase AbbVie stock in the Plan. AbbVie dividends are invested in the Plans default investment option.
Participants may direct the Trustee to sell all or a portion of the Abbott and AbbVie common shares held in their accounts and reinvest the proceeds in any of the other investment options available to the participants.
Participants are at all times fully vested in their own contributions and earnings thereon. Vesting in employer contributions and earnings thereon is based on the following vesting schedule:
|
|
Vesting |
|
Service |
|
percentage |
|
Less than two years |
|
0 |
% |
Two years or more |
|
100 |
% |
Non-vested portions of employer contributions and earnings thereon are forfeited as of an employees termination date. Forfeitures are used to (1) restore any forfeitures of participants who returned to service with the Company within a given period of time, (2) pay Plan expenses and (3) reduce future employer contributions if terminated participants do not return to service within the given period of time. In 2016, no forfeitures were used to reduce Abbotts employer contributions. Forfeitures totaling approximately $36,000 were available at the end of 2016 and no forfeitures were available at the end of 2015.
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE A - DESCRIPTION OF THE PLAN - Continued
Distributions and In-Service Withdrawals
Following retirement, termination or death, participants or their beneficiaries may elect to receive a distribution in installments, a single lump sum or a partial lump sum. Participants may elect a direct rollover of their accounts. Distribution must be made by the 1st of April following the year the participant reaches age 70 ½ or, if earlier, the 1st of April following the year in which the participant dies. Interest, dividends and other earnings will continue to accrue on such deferred amounts.
Prior to termination, participants are permitted to withdraw their after-tax contributions (after-tax contributions made on or after January 8, 2016 may be withdrawn from the Plan only after being held for two or more years) and rollover contributions (including Roth rollover accounts and merged-in plan rollover accounts) and, after age 59 ½, may also withdraw pretax contributions. Distributions are made in cash or, to the extent contained in the participants account, a participant may elect distribution of Abbott and AbbVie common shares, and in each case, are subject to certain limitations.
Notes Receivable from Participants
Participants may convert their vested accounts to one or two loans to themselves. The borrowing may not exceed the lesser of the current market value of the assets allocated to their vested accounts or 50% of all of their Plan accounts up to $50,000, subject to Puerto Rico Internal Revenue Code limitations and restrictions. Participants pay interest on such borrowings at the prime rate in effect at the time the participant loan is made. Loans must be repaid within five years (or by the employees anticipated retirement date, if sooner) unless the loan is used for the purchase of the primary residence of the employee, in which case the repayment period can be extended to a period of fifteen years (or until the employees anticipated retirement date, if sooner). Repayment is generally made through periodic payroll deductions or by sending in a payment, but a loan may be repaid in a lump sum at any time. Post-termination loan repayments are permitted. For employees whose account is distributed during the repayment period, the balance of the outstanding loan is netted from their Plan distribution.
NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Accounting
The financial statements have been prepared using the accrual basis of accounting.
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Continued
Adoption of New Accounting Rules
In May 2015, the Financial Accounting Standards Board issued updated guidance related to fair value measurement and the disclosures for investments in certain entities that calculate net asset value (NAV) per share (or its equivalent). The updated guidance applies to reporting entities that elect to measure the fair value of certain investments using the NAV per share (or its equivalent) of the investment as a practical expedient. Prior to the updated guidance, investments valued using the practical expedient were categorized within the fair value hierarchy on the basis of when the investment is redeemable with the investee at NAV. The amendments remove the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the NAV per share practical expedient.
The amendments are effective for the Plan for fiscal years beginning after December 15, 2016 and apply retrospectively to all periods presented. Earlier application is permitted. The Plans administrator elected to adopt the amendments for the year ended December 31, 2016. Accordingly, the amendment was retrospectively applied resulting in the removal of the investments for which fair value is measured using the NAV per share practical expedient from the fair value tables in the Investment Valuation note. The total amount of the investments measured at NAV is disclosed so that total investments in the fair value tables can be reconciled to total investments at fair value on the statements of net assets.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and changes therein, and disclosure of contingent assets and liabilities. Actual results may differ from those estimates.
Investment Valuation
Plan management uses the following methods and significant assumptions to estimate the fair value of investments:
Common stock and mutual funds - Valued at the published market price per share or unit multiplied by the number of shares or units held.
Collective trust funds - Valued at the NAV provided by the administrator of the fund. The NAV is used as a practical expedient to estimate fair value. The NAV is based on the value of the underlying assets owned by the fund, minus its liabilities, and then divided by the number of shares outstanding. Redemption is permitted daily.
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
Investment Valuation - Continued
The following tables summarize the basis used to measure investments at fair value at December 31, 2016 and 2015 (dollars in thousands):
|
|
Basis of Fair Value Measurement |
|
|
| |||||||||||
2016 |
|
Quoted |
|
Significant |
|
Significant |
|
Measured at |
|
Total |
| |||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Common stock |
|
$ |
56,787 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
56,787 |
|
Mutual funds |
|
32,724 |
|
|
|
|
|
|
|
32,724 |
| |||||
Collective trust funds |
|
|
|
|
|
|
|
27,547 |
|
27,547 |
| |||||
Total investments at fair value |
|
$ |
89,511 |
|
$ |
|
|
$ |
|
|
$ |
27,547 |
|
$ |
117,058 |
|
|
|
Basis of Fair Value Measurement |
|
|
| |||||||||||
2015 |
|
Quoted |
|
Significant |
|
Significant |
|
Measured at |
|
Total |
| |||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Common stock |
|
$ |
60,145 |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
60,145 |
|
Mutual funds |
|
41,048 |
|
|
|
|
|
|
|
41,048 |
| |||||
Collective trust funds |
|
|
|
|
|
|
|
11,916 |
|
11,916 |
| |||||
Total investments at fair value |
|
$ |
101,193 |
|
$ |
|
|
$ |
|
|
$ |
11,916 |
|
$ |
113,109 |
|
Notes Receivable from Participants
Notes receivable from participants are measured at their unpaid balance plus any accrued but unpaid interest. Delinquent loans are reclassified as distributions based upon the terms of the Plan. No allowance for credit losses has been recorded as of December 31, 2016 or 2015.
Income Recognition
Purchases and sales of securities are recorded on a trade-date basis. Interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. Net realized and unrealized appreciation/depreciation is recorded in the accompanying statement of changes in net assets available for benefits as net depreciation in fair value of investments.
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
Administrative Expenses
Participants are charged transaction fees for loan processing and commissions on purchases and sales of Abbott shares and sales of AbbVie shares. Investment fees for mutual funds, collective trusts, and money market funds are charged against the net assets of the respective fund. The Company pays other record-keeping and administration fees, where applicable.
Payment of Benefits
Benefits are recorded when paid.
NOTE C - INVESTMENTS
Distributions of Abbott common shares and conversions of participants common share account balances to participant loans or other investment options are recorded at fair market value.
A summary of Abbott common share data as of December 31, 2016 and 2015 is presented below:
|
|
2016 |
|
2015 |
| ||
Abbott common shares, 863,060 and 812,354 shares, respectively (dollars in thousands) |
|
$ |
33,150 |
|
$ |
36,483 |
|
Market value per share |
|
$ |
38.41 |
|
$ |
44.91 |
|
In general, the investments provided by the Plan are exposed to various risks, such as interest rate, credit and overall market volatility risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participant accounts and the amounts reported in the statements of net assets available for benefits.
NOTE D - RELATED-PARTY AND PARTY-IN-INTEREST TRANSACTIONS
A significant portion of the Plans assets is invested in Abbott common shares.
Participants pay fees to the recordkeeper for loan transaction processing and for commissions on purchases and sales of Abbott shares and sales of AbbVie stock. These transactions qualify as permitted party-in-interest transactions.
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE E - PLAN TERMINATION
The Plan may be terminated at any time by Abbott upon written notice to the Trustee and Committee. All participants account balances would become fully vested upon Plan termination. Upon termination of the Plan, distributions of each participants share in the trust, as determined by the terms of the Plan, would be made to each participant. At the present time, Abbott has no intention of terminating the Plan.
NOTE F - TAX STATUS
The Plan received a letter dated April 19, 2016 from the Department of the Treasury of the Commonwealth of Puerto Rico that the Plan, as written, qualifies under Section 1081.01(a) of the Puerto Rico Internal Revenue Code of 2011, as amended and, consequently, its enabling trust is exempt from local income tax. The Plan has been amended since receiving the letter. The Plan administrator believes that the Plan is designed and is currently being operated, in all material respects, in accordance with the applicable Puerto Rico Internal Revenue Code.
Accounting principles generally accepted in the United States of America require Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the organization has taken an uncertain position that more likely than not would not be sustained upon examination by the applicable taxing authorities. The Plan administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2016 and 2015, there are no uncertain positions taken or expected to be taken that would require recognition of a liability or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits in progress.
NOTE G SUBSQUENT EVENTS
The Company has evaluated subsequent events from December 31, 2016 through the date these financial statements were issued. Other than described below, there were no subsequent events that require recognition or additional disclosure in these financial statements.
In January 2017, Abbott completed the acquisition of St. Jude Medical, Inc., a global medical device manufacturer. St. Jude Medical, LLC employees in Puerto Rico are eligible to participate in a separate plan, not the Plan.
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
NOTES TO FINANCIAL STATEMENTS - CONTINUED
December 31, 2016 and 2015
NOTE G SUBSQUENT EVENTS - Continued
In February 2017 Abbott completed the sale of Abbott Medical Optics (AMO), its vision care business, to Johnson & Johnson. AMO employees in Puerto Rico are no longer eligible to make contributions to the Plan. AMO participants may keep their account balance in the Plan, roll over their account to a personal rollover account or a qualified plan, such as the Johnson & Johnson Retirement Savings Plan, or take a distribution subject to taxes and penalties. If an AMO participant elects to rollover their account to the Johnson & Johnson Retirement Savings Plan and the participant has an outstanding loan, for a limited time the loan balance may be rolled over to the Johnson & Johnson Retirement Savings Plan and loan repayments will continue at Johnson & Johnson.
Beginning March 2017, newly hired employees in certain specified Abbott divisions and business units participate in the Plan under a different structure (Abbott Green employees). Under the Abbott Green structure, participants may defer up to 50% of compensation as pre-tax contributions. Effective with the first pay period ending after March 1, 2017, for Abbott Green employees who complete at least six months of eligibility service, matching contributions will be made at the rate of 100% of up to a 3% deferral of eligible compensation. A true-up matching contribution will be made for eligible participants as of the end of the year if necessary to reach a full 1-3% matching contribution, as applicable. The Abbott Green matching contributions vest 20% each year, until full vesting at five years (with accelerated vesting if the participant dies, attains age 65, or becomes disabled).
Abbott Laboratories Stock Retirement Plan (Puerto Rico)
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
December 31, 2016
(Dollars in thousands)
Identity of party involved/ |
|
|
|
Current |
| |
description of asset |
|
Cost (a) |
|
value |
| |
|
|
|
|
|
| |
Common stock - employer securities |
|
|
|
|
| |
*Abbott Laboratories |
|
|
|
$ |
33,150 |
|
|
|
|
|
|
| |
Common stock |
|
|
|
|
| |
AbbVie Inc., common stock |
|
|
|
23,637 |
| |
Total Common stock |
|
|
|
56,787 |
| |
|
|
|
|
|
| |
Mutual funds |
|
|
|
|
| |
American Funds EuroPacific Growth Fund |
|
|
|
4,534 |
| |
American Funds The Growth Fund of America |
|
|
|
7,271 |
| |
American Funds The Investment Company of America Fund |
|
|
|
5,887 |
| |
American Funds Washington Mutual Investors Fund |
|
|
|
2,143 |
| |
PIMCO All Asset Fund |
|
|
|
2,195 |
| |
PIMCO Short Asset Investment Fund |
|
|
|
8,289 |
| |
Vanguard Mid-Cap Value Index Fund Admiral |
|
|
|
2,405 |
| |
Total Mutual funds |
|
|
|
32,724 |
| |
|
|
|
|
|
| |
Collective trust funds |
|
|
|
|
| |
Blackrock International Opportunities Fund |
|
|
|
1,288 |
| |
*Northern Trust Collective World ex-U.S. Index Fund |
|
|
|
633 |
| |
*Northern Trust Collective ACWI ex-U.S. Index Fund |
|
|
|
29 |
| |
PIMCO Total Return Collective Trust Fund |
|
|
|
2,660 |
| |
SSGA Russell Small/Mid Cap Index Fund |
|
|
|
2,679 |
| |
SSGA S&P 500 Index Fund |
|
|
|
4,419 |
| |
SSGA U.S. Bond Index Fund |
|
|
|
4 |
| |
SSGA Target Retirement 2015 |
|
|
|
517 |
| |
SSGA Target Retirement 2020 |
|
|
|
4,393 |
| |
SSGA Target Retirement 2025 |
|
|
|
2,863 |
| |
SSGA Target Retirement 2030 |
|
|
|
2,014 |
| |
SSGA Target Retirement 2035 |
|
|
|
1,430 |
| |
SSGA Target Retirement 2040 |
|
|
|
1,018 |
| |
SSGA Target Retirement 2045 |
|
|
|
408 |
| |
SSGA Target Retirement 2050 |
|
|
|
162 |
| |
SSGA Target Retirement 2055 |
|
|
|
19 |
| |
SSGA Target Retirement 2060 |
|
|
|
6 |
| |
SSGA Target Retirement Income |
|
|
|
359 |
| |
Wellington Mid-Cap Growth Fund |
|
|
|
2,248 |
| |
*Northern Trust Collective Short Term Investment Fund |
|
|
|
398 |
| |
Total Collective trust funds |
|
|
|
27,547 |
| |
|
|
|
|
|
| |
*Loans to participants, 3.25% to 8.75% |
|
|
|
6,246 |
| |
|
|
|
|
|
| |
|
|
|
|
$ |
123,304 |
|
*Represents a party-in-interest transaction.
(a) Cost information omitted as all investments are fully participant directed.
EXHIBITS
23.1 |
|
Consent of Independent Registered Public Accounting Firm Abbott Laboratories Stock Retirement Plan. |
|
|
|
23.2 |
|
Consent of Independent Registered Public Accounting Firm Abbott Laboratories Stock Retirement Plan (Puerto Rico). |
SIGNATURE
The Plan. Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
ABBOTT LABORATORIES STOCK RETIREMENT PROGRAM
Date: June 28, 2017 |
By: |
/s/ Mary K. Moreland |
|
|
Mary K. Moreland |
|
|
Plan Administrator |
EXHIBIT INDEX
Exhibit No. |
|
Exhibit |
|
|
|
|
|
23.1 |
|
Consent of Independent Registered Public Accounting Firm Abbott Laboratories Stock Retirement Plan. |
|
|
|
|
|
23.2 |
|
Consent of Independent Registered Public Accounting Firm Abbott Laboratories Stock Retirement Plan (Puerto Rico). |
|
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated June 28, 2017, with respect to the financial statements and supplemental schedule included in the Annual Report of Abbott Laboratories Stock Retirement Plan on Form 11-K for the year ended December 31, 2016. We hereby consent to the incorporation by reference of said report in Abbott Laboratories previously filed S-8 Registration Statements for the Abbott Laboratories Stock Retirement Program as follows:
File No. |
|
Effective date |
33-26685 |
|
January 23, 1989 |
33-50452 |
|
August 4, 1992 |
33-51585 |
|
December 20, 1993 |
33-56897 |
|
December 16, 1994 |
33-65127 |
|
December 18, 1995 |
333-19511 |
|
January 10, 1997 |
333-43383 |
|
December 29, 1997 |
333-69579 |
|
December 23, 1998 |
333-93257 |
|
December 21, 1999 |
333-74224 |
|
November 30, 2001 |
333-102180 |
|
December 23, 2002 |
333-109253 |
|
September 29, 2003 |
333-124849 |
|
May 12, 2005 |
333-141116 |
|
March 7, 2007 |
333-153198 |
|
August 26, 2008 |
333-169888 |
|
October 12, 2010 |
333-204772 |
|
June 5, 2015 |
/s/ Grant Thornton LLP |
|
|
|
Chicago, Illinois |
|
June 28, 2017 |
|
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated June 28, 2017, with respect to the financial statements and supplemental schedule included in the Annual Report of Abbott Laboratories Stock Retirement Plan (Puerto Rico) on Form 11-K for the year ended December 31, 2016. We hereby consent to the incorporation by reference of said report in Abbott Laboratories previously filed S-8 Registration Statements for the Abbott Laboratories Stock Retirement Program as follows:
File No. |
|
Effective date |
33-26685 |
|
January 23, 1989 |
33-50452 |
|
August 4, 1992 |
33-51585 |
|
December 20, 1993 |
33-56897 |
|
December 16, 1994 |
33-65127 |
|
December 18, 1995 |
333-19511 |
|
January 10, 1997 |
333-43383 |
|
December 29, 1997 |
333-69579 |
|
December 23, 1998 |
333-93257 |
|
December 21, 1999 |
333-74224 |
|
November 30, 2001 |
333-102180 |
|
December 23, 2002 |
333-109253 |
|
September 29, 2003 |
333-124849 |
|
May 12, 2005 |
333-141116 |
|
March 7, 2007 |
333-153198 |
|
August 26, 2008 |
333-169888 |
|
October 12, 2010 |
333-204772 |
|
June 5, 2015 |
/s/ Grant Thornton LLP |
|
|
|
Chicago, Illinois |
|
June 28, 2017 |
|